Can Axon Enterprise (AXON) Stock Reach $660?

Axon Enterprise, Inc. (AXON) is the Scottsdale, Arizona-based public-safety technology company behind the TASER conducted-energy device, body-worn cameras, and a growing cloud software ecosystem that includes Axon Evidence, the AI report-writing tool Draft One, Fusus real-time crime-center software, and Dedrone counter-drone technology. The question facing investors is whether a stock trading near $393 can climb to a widely discussed $660 level.

Key Takeaways

• The central $660 target is the arithmetic mean of nine current analyst price targets, rounded from roughly $657; the individual targets span $470 to $825.
• At the latest price near $392.64, reaching $660 would require a gain of about 68%, a very large move.
• Broader Street data shows roughly 21 analysts with an average "Buy" rating and website consensus averages near $691 to $707.
• The strongest supports are 30%-plus revenue growth, accelerating annual recurring revenue, and expansion into AI, drones, and enterprise markets.
• The biggest risks are a premium valuation, decelerating order metrics, and a $1 billion convertible-note offering that stirred dilution concerns.

Analyst Price Targets and Consensus View

This analysis aggregates nine verifiable, current individual price targets rather than relying on any single website's headline figure. The targets reviewed were: Piper Sandler at $561 (Overweight, October 20, 2026), UBS at $470 (Neutral, October 13, 2026), Raymond James at $675 (Buy, October 15, 2026), RBC Capital at $735 (Buy, September 29, 2026), TD Cowen at $825 (Buy, September 11, 2026), Argus Research at $600 (Buy, September 3, 2026), Morgan Stanley at $640 (Overweight, August 5, 2026), Goldman Sachs at $715 (Buy, August 6, 2026), and Barclays at $688 (Overweight, August 2026).

The mean of these nine targets is approximately $657, rounded to a $660 central target. The range is unusually wide — from $470 at the cautious end to $825 at the bullish end — reflecting genuine disagreement about how much premium valuation the company's growth deserves. For context, broader aggregators show about 21 analysts with a consensus "Buy" or "Moderate Buy" rating and average targets of roughly $690.68 (S&P Global) to $707.07 (MarketBeat).

Recent revisions cut both ways. Piper Sandler trimmed its target from $732 to $561 on valuation concerns while keeping an Overweight rating, and UBS lowered its target from $600 to $470. In contrast, Argus raised its target to $600 from $460, and Morgan Stanley and Goldman Sachs lifted theirs over the summer. The cautious camp emphasizes stretched multiples and softer order trends, while bulls point to durable growth and a large underpenetrated addressable market.

Current Market Position and Path Toward the Target

Axon shares closed near $392.64, roughly 49% below their 52-week high of $764.02 and down about 32% year to date. Reaching $660 implies upside of about 68%, which is best characterized as a very large move — not a modest re-rating but a substantial recovery that would retrace much of the recent drawdown.

The underlying business remains strong by most measures. Second-quarter 2026 revenue rose about 35% to $904 million, marking the tenth consecutive quarter of 30%-plus growth, and management raised its full-year outlook. Annual recurring revenue (ARR) grew about 39%, with net revenue retention near 126%. Yet the stock has de-rated, and its trailing price-to-earnings (P/E) ratio sits near 160 with a forward P/E around 43, leaving the path to $660 heavily dependent on sustained execution and stabilizing sentiment.

What Could Support a Move Toward the Target

• Durable growth. Software and Services is the largest revenue segment, and recurring revenue provides visibility that supports premium multiples when confidence is high.
• AI and drone expansion. Draft One, Axon Assistant, Fusus, and Dedrone broaden the platform beyond hardware into higher-margin software and analytics.
• Contract momentum. Recent awards include a roughly $235 million, 10-year Los Angeles Police Department renewal (pending final approval), a $40 million Atlanta Police expansion, and roughly $37 million in ICE work.
• New verticals. Enterprise, healthcare, retail, corrections, and international markets remain early-stage growth opportunities.

What Could Prevent the Target From Being Reached

• Valuation compression. Even after the decline, Axon trades at a growth multiple that leaves little room for execution missteps.
• Mixed order metrics. Some analysts describe recent bookings growth as disappointing relative to history, a key watch item.
• Dilution and leverage. The $1 billion, 0% convertible senior notes due 2031 added uncertainty around future share dilution and cash conversion.
• Regulatory and political scrutiny. Automated license-plate recognition and AI surveillance face growing oversight, and some local projects have been delayed or rejected.
• Competition. Rivals such as Motorola Solutions and Flock Safety compete in adjacent public-safety and surveillance markets.

Technical Levels and Market Structure

Axon trades below both its 50-day moving average near $497 and its 200-day moving average near $475, a bearish-to-oversold structure. The 52-week low around $339 is the primary nearby support, while the 52-week high of $764 represents the major resistance zone a move toward $660 would need to break through. A relative strength index near 30 signals oversold conditions but does not by itself indicate a durable bottom.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of about 12 months, though individual firms vary and rarely state an exact date. The next earnings report is scheduled for November 3, 2026. Investors should watch revenue and ARR growth, net new bookings, guidance, margin trends, federal and municipal contract activity, any changes to the convertible-note conversion terms, and analyst target revisions. Macroeconomic factors, including interest rates and government budget cycles, also matter because Axon sells largely to public-sector customers.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. For a volatile, high-multiple name like Axon, such tools can help traders spot changing trends, monitor existing positions, and surface opportunities more efficiently than manual scanning. Explore the AI Daily Buy/Sell Signals to see how algorithmic monitoring can support your own decision-making.

Final Assessment

The $660 central target, derived from the average of nine current analyst price targets, sits well above the recent price near $393 and implies a very large gain of about 68%. Achieving it would likely require Axon to sustain 30%-plus growth, accelerate recurring-revenue and order momentum, and persuade the market to re-apply a premium multiple. The principal obstacles are valuation, mixed order signals, dilution from the convertible offering, and regulatory scrutiny of surveillance technology. The wide $470-to-$825 target range underscores how differently analysts weigh those forces. Whether Axon can reach $660 is an open question that depends on execution and sentiment, not a forecast — and investors should focus on the data points above rather than any single price level.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations